Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012169213
Sun, 07.01.2024
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
Venlo, the Netherlands, January 7, 2024 – QIAGEN N.V. announces a plan to return up to approximately $300 million (maximum EUR 273 million) to shareholders through a synthetic share repu [ … ]
Tue, 26.07.2022
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN increases full-year 2022 outlook
Venlo, The Netherlands, July 26, 2022 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that it has increased the outlook for full-year 2022 in terms of net sales and adjusted diluted earnings per share (EPS).
QIAGEN increa [ … ]
Tue, 26.07.2022
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN increases full-year 2022 outlook
Venlo, The Netherlands, July 26, 2022 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that it has increased the outlook for full-year 2022 in terms of net sales and adjusted diluted earnings per share (EPS).
QIAGEN increa [ … ]
Tue, 26.04.2022
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN increases full-year 2022 outlook
Venlo, The Netherlands, April 26, 2022 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that it has increased the outlook for full-year 2022 in terms of net sales and adjusted diluted earnings per share (EPS).
Net sales ar [ … ]
Mon, 12.07.2021
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN announces preliminary Q2 2021 results and updates 2021 outlook
Venlo, the Netherlands, July 12, 2021 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces preliminary results for the second quarter of 2021 that exceeded the outlook for net sales and adjusted ea [ … ]
Mon, 12.07.2021
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN to conduct an additional up to USD 100 million share repurchase program
Venlo, The Netherlands, July 12, 2021 - QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has today passed a resolution to exercise the authorization granted by t [ … ]
Thu, 10.12.2020
QIAGEN N.V.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. NOT FOR DISTRIBUTION TO ANY U.S. PERSON. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Ad-hoc announcement pursuant to A [ … ]
Tue, 27.10.2020
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN increases full-year 2020 outlook
Venlo, the Netherlands, October 27, 2020 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that it has increased the outlook for full-year 2020 net sales growth to about 20% at constant exchange rates (CER) (prior outlook of [ … ]
Tue, 13.10.2020
QIAGEN N.V.
QIAGEN reports strong preliminary results for third quarter of 2020
Venlo, The Netherlands, October 13, 2020 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020.
Net sales grew 26% at actual rates, and also rose 26% at constant exchange [ … ]
Fri, 21.08.2020
QIAGEN N.V.
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
Resignation of Chairman of the Supervisory Board
Venlo, The Netherlands, August 21, 2020 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that Dr. Håkan Björklund, Chairman of the Supervisory Board, has resigned from office as Chairman of the Supervisory Board wi [ … ]